NIELSEN, Peter G.,THOMSEN, Mikael S.,HOJGAARD, Bent
申请号：
PH12017501509
公开号：
PH12017501509A1
申请日:
2017.08.18
申请国别(地区):
PH
年份:
2018
代理人:
摘要：
The present invention relates to a controlled release formulation comprising the active compounds tesofensine and a beta blocker, such as metoprolol or carvedilol, or a pharmaceutically acceptable salt thereof. The invention further relates to use of the controlled release formulation in a method of treatment of diabetes, obesity or an obesity associated disorder.
